Kailera Therapeutics, Inc. (KLRA)
Nasdaq: KLRA · CIK 0002096997 · United States
Every official Kailera Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open KLRA filings
Kailera Therapeutics, Inc. documents
- Kailera Therapeutics, Inc. 10-K 2026KLRA 10-K 2026: annual report for fiscal 2026
- Kailera Therapeutics, Inc. 10-K 2025KLRA 10-K 2025: annual report for fiscal 2025
- Kailera Therapeutics, Inc. 10-K 2024KLRA 10-K 2024: annual report for fiscal 2024
- Kailera Therapeutics, Inc. 10-K 2023KLRA 10-K 2023: annual report for fiscal 2023
- Kailera Therapeutics, Inc. 10-K 2022KLRA 10-K 2022: annual report for fiscal 2022
- Kailera Therapeutics, Inc. 10-Q 2026KLRA 10-Q 2026: quarterly report for fiscal 2026
- Kailera Therapeutics, Inc. 10-Q 2025KLRA 10-Q 2025: quarterly report for fiscal 2025
- Kailera Therapeutics, Inc. 10-Q 2024KLRA 10-Q 2024: quarterly report for fiscal 2024
- Kailera Therapeutics, Inc. 10-Q 2023KLRA 10-Q 2023: quarterly report for fiscal 2023
- Kailera Therapeutics, Inc. 10-Q 2022KLRA 10-Q 2022: quarterly report for fiscal 2022
- Kailera Therapeutics, Inc. 8-K 2026KLRA 8-K 2026: current report for fiscal 2026
- Kailera Therapeutics, Inc. 8-K 2025KLRA 8-K 2025: current report for fiscal 2025
- Kailera Therapeutics, Inc. 8-K 2024KLRA 8-K 2024: current report for fiscal 2024
- Kailera Therapeutics, Inc. 8-K 2023KLRA 8-K 2023: current report for fiscal 2023
- Kailera Therapeutics, Inc. 8-K 2022KLRA 8-K 2022: current report for fiscal 2022
- Kailera Therapeutics, Inc. DEF 14A 2026KLRA DEF 14A 2026: proxy statement for fiscal 2026
- Kailera Therapeutics, Inc. DEF 14A 2025KLRA DEF 14A 2025: proxy statement for fiscal 2025
- Kailera Therapeutics, Inc. DEF 14A 2024KLRA DEF 14A 2024: proxy statement for fiscal 2024
- Kailera Therapeutics, Inc. DEF 14A 2023KLRA DEF 14A 2023: proxy statement for fiscal 2023
- Kailera Therapeutics, Inc. DEF 14A 2022KLRA DEF 14A 2022: proxy statement for fiscal 2022
- Kailera Therapeutics, Inc. Form 4 2026KLRA Form 4 2026: insider trading filing for fiscal 2026
- Kailera Therapeutics, Inc. Form 4 2025KLRA Form 4 2025: insider trading filing for fiscal 2025
- Kailera Therapeutics, Inc. Form 4 2024KLRA Form 4 2024: insider trading filing for fiscal 2024
- Kailera Therapeutics, Inc. Form 4 2023KLRA Form 4 2023: insider trading filing for fiscal 2023
- Kailera Therapeutics, Inc. Form 4 2022KLRA Form 4 2022: insider trading filing for fiscal 2022
- Kailera Therapeutics, Inc. S-1 2026KLRA S-1 2026: registration statement for fiscal 2026
- Kailera Therapeutics, Inc. S-1 2025KLRA S-1 2025: registration statement for fiscal 2025
- Kailera Therapeutics, Inc. S-1 2024KLRA S-1 2024: registration statement for fiscal 2024
- Kailera Therapeutics, Inc. S-1 2023KLRA S-1 2023: registration statement for fiscal 2023
- Kailera Therapeutics, Inc. S-1 2022KLRA S-1 2022: registration statement for fiscal 2022
- Kailera Therapeutics, Inc. 13F 2026KLRA 13F 2026: institutional holdings for fiscal 2026
- Kailera Therapeutics, Inc. 13F 2025KLRA 13F 2025: institutional holdings for fiscal 2025
- Kailera Therapeutics, Inc. 13F 2024KLRA 13F 2024: institutional holdings for fiscal 2024
- Kailera Therapeutics, Inc. 13F 2023KLRA 13F 2023: institutional holdings for fiscal 2023
- Kailera Therapeutics, Inc. 13F 2022KLRA 13F 2022: institutional holdings for fiscal 2022
More companies